Cognitive Behavioral Therapy for Insomnia

(RESET Trial)

This trial explores how Cognitive Behavioral Therapy for Insomnia (CBT-I) can improve sleep and reduce stress-related issues. The researchers aim to understand how changes in cortisol (a stress hormone) and stress response affect sleep quality. Participants will receive either 4 weeks or 10 weeks of CBT-I to assess how different treatment durations impact sleep. Individuals with chronic insomnia who typically sleep less than six hours per night might be suitable for this study. As an unphased trial, this study provides a unique opportunity to contribute to understanding how CBT-I can enhance sleep and alleviate stress.

Yes, you will need to stop taking any sleep medications or medications that affect sleep or cortisol levels to participate in this trial.

Studies have shown that Cognitive Behavioral Therapy for Insomnia (CBT-I) is safe and easy to manage. Research indicates that CBT-I can be as effective as sleep medication, but without side effects. This makes it a preferred first choice for treating insomnia. Those who have tried CBT-I not only sleep better but also experience fewer recurrences of insomnia. Overall, CBT-I is a safe option for individuals dealing with long-term sleep issues.¹²³⁴⁵

Researchers are excited about Cognitive Behavioral Therapy for Insomnia (CBT-I) because it offers a non-drug approach to treating insomnia, unlike traditional options like sleep medications. CBT-I works by addressing the underlying behaviors and thoughts that contribute to sleep problems, potentially leading to long-lasting improvements in sleep quality. Additionally, the trial is exploring different lengths of therapy, with a 4-week and a 10-week option, to determine the most effective duration for patients. This personalized approach could make CBT-I a more flexible and sustainable option for those struggling with insomnia.

Research has shown that Cognitive Behavioral Therapy for Insomnia (CBT-I) effectively reduces insomnia symptoms. In one study, all groups receiving CBT-I experienced a significant reduction in symptoms. Another study found that CBT-I increased total sleep time by 8 minutes and improved sleep efficiency by 10%. The results of CBT-I are comparable to those of sleep medication but without the side effects. Long-term benefits have been observed, with positive effects lasting up to ten years, and many participants no longer meeting the criteria for insomnia. This trial will compare two different durations of CBT-I: a 4-week program and a 10-week program. Overall, CBT-I is considered a top treatment for chronic insomnia due to its proven effectiveness.¹⁴⁶⁷⁸